Risk factors for positive postpartum depression screen in women with private health insurance and access to care. (17th December 2019)

• Record Type: Journal Article
• Authors: Soffer, Marti D.; Adams, Zoe M.; Chen, Yiting S.; Fox, Nathan S.
• Is Part Of: Journal of maternal-fetal & neonatal medicine. Volume 32:Number 24(2019)
• Page Start: 4154
• Page End: 4158
• Publication Date: 2019-12-17
• Subjects: Access to care -- Edinburgh -- health insurance -- postpartum depression; Obstetrics -- Periodicals; Perinatology -- Periodicals; Infants (Newborn) -- Diseases -- Periodicals; Neonatology -- Periodicals; 618.2
• DOI: 10.1080/14767058.2018.1484096
• Languages: English
• ISSNs: 1476-7058

Abstract

Abstract: Objective: To determine risk factors for a positive postpartum depression screen among women with private health insurance and 24/7 access to care. Study design: Retrospective cohort study of all patients delivered by a single MFM practice from April 2015 to September 2016. All patients had private health insurance and 24/7 access to care. All patients were scheduled to undergo the Edinburgh Postnatal Depression Scale (EPDS) at their 6-week postpartum visit and a positive screen was defined as a score of 10 or higher, or a score greater than zero on question 10 (thoughts of selfharm). Using logistic regression, risk factors for postpartum depression were compared between women with and without a positive screen. Results: Of the 1237 patients delivered, 1113 (90%) were screened with the EPDS. 81 patients (7.3, 95%CI 5.9–9.0%) of those tested had a positive screen. On regression analysis, risk factors associated with a positive screen were nulliparity (aOR 1.8, 95%CI 1.1, 2.9), cesarean delivery (aOR 1.7, 95%CI 1.1, 2.8), non-White race (aOR 2.0, 95%CI 1.1, 3.5), and a history of depression or anxiety (aOR 4.6, 95%CI 2.6, 8.1). Among the 100 women with a history of depression or anxiety, selective serotonin reuptake inhibitor (SSRI) use in the postpartum period was not associated with a reduced risk of a positive screen (25.5% in those taking an SSRI versus 18.4% of those not taking an SSRI, p = .39). Conclusions: Among women with private health insurance and access to care, the incidence of a positive screen for postpartum depression is approximately 7%. The use of an SSRI did not eliminate this risk. All women should be screened for postpartum depression.